首页 | 本学科首页   官方微博 | 高级检索  
     


Biosimilar erythropoietin in anemia treatment (BEAT)—Efficacy and safety of a 1:1 dose conversion from EPREX® to EPIAO® in patients with end-stage renal disease on hemodialysis: A prospective,randomized, double blind,parallel group study
Authors:Bolong Miao  Alina Nikolaevna Isachkina  Evgeny Viktorovich Shutov  Alexander Alekseevich Selyutin  Lyudmila Vladimirovna Kvitkova  Valery Yuryevich Shilo  Olga Nikolaevna Vetchinnikova  Ilya Vyacheslavovich Alexandrov  Dmitry Vladislavovich Perlin  Alexander Vasilievich Zuev  Igor Leonidovich Davydkin  Tatyana Pavlovna Mironova  Olga Mikhailovna Solovyova  Alexey Pavlovich Tutin  Alexey Mikhailovich Omelchenko  Kriengsak Vareesangthip  Nadezhda Georgievna Khadikova  Man Li  Xiang Li
Abstract:
Keywords:biosimilar EPO, chronic kidney disease, EPIAO®  , epoetin, erythropoietin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号